Utilization: as hypolipidemial agent in medicine. Essence of invention: product propanolamide of 2-thiazolylamide of citraconic acid. EC C11H15O3N3S, yield 70 , temperature +146-148 DEGREE C. Reagent 1: 2-thyazolylamide of citraconic acid. Reagent 2: propanolamine. Reaction conditions: at ambient temperature in acetone media.

摘要

The method for providing the specified efficacy of the laser therapy consists in changing the output power of laser irradiation in the course of the procedures. The minimally admissible efficacy of the laser therapy is specified.